Work

P75.12 Prognostic Value of Neutrophil to Lymphocyte Ratio in NSCLC Patients Receiving First Line Immune Checkpoint Inhibitor Therapy

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.01.1046

Authors: N. Surya, M. Li, S. Zhao, L. Wei, S. Patel, G. Lopez, A. Johns, M. Grogan, E. Bertino, K. He, P. Shields, D. Carbone, G. Otterson, C. Presley, D. Owen

Institutions: The Ohio State University, The Ohio State University Wexner Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Language: English

Topic: Inflammatory Biomarkers in Disease Prognosis

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3138037433

Cites:

Cited by:

Related to: 10